Increased circulating Th17 cells and altered CD4 T cell maturation and differentiation in active tuberculosis with type 2 diabetes: a pilot study

This pilot study reveals CD4 T cell alterations in T2D that likely worsen TB outcomes. A reduced naïve CD4 T cell pool, increased central memory and antigen-activated CD4 T cells, and elevated Th1 and three Th17 cell subsets suggest a pro-inflammatory environment favoring responses that may promote, rather than control TB. These findings highlight immune dysfunctions that could be targeted by host-directed therapies to prevent TB and improve outcomes in T2D patients.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-09-09
DOI
https://doi.org/10.3389/fimmu.2025.1637868
Citations
1
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
1.40

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Increased circulating Th17 cells and altered CD4 T cell maturation and differentiation in active tuberculosis with type 2 diabetes: a pilot study

Génesis P. Aguillón-Durán, Raúl Loera-Salazar, Paul Ogongo, Esperanza M. García-Oropesa et al.
1 citations
Frontiers in Immunology
Tuberculosis Research and Epidemiology
1.40
article

Increased circulating Th17 cells and altered CD4 T cell maturation and differentiation in active tuberculosis with type 2 diabetes: a pilot study

Génesis P. Aguillón-Durán, Raúl Loera-Salazar, Paul Ogongo, Esperanza M. García-Oropesa, Yoscelina Estrella Martínez-López, America M. Cruz-Gonzalez, Javier E. Rodríguez-Herrera, Luis A. Garza, Blanca I. Restrepo, Cecilia S. Lindestam Arlehamn, J. Ernst, Anthony Tran, A Sette, Ilse A. Dominguez-Trejo
article en
1 citations

Abstract

This pilot study reveals CD4 T cell alterations in T2D that likely worsen TB outcomes. A reduced naïve CD4 T cell pool, increased central memory and antigen-activated CD4 T cells, and elevated Th1 and three Th17 cell subsets suggest a pro-inflammatory environment favoring responses that may promote, rather than control TB. These findings highlight immune dysfunctions that could be targeted by host-directed therapies to prevent TB and improve outcomes in T2D patients.

Frontiers in ImmunologyVol. 16
Statens Serum Institut (DK), Texas Biomedical Research Institute (US), La Jolla Institute for Immunology (US), University of California, San Francisco (US), The University of Texas Rio Grande Valley (US), University of California System (US), University of California San Diego (US), Universidad México Americana del Norte (MX), Autonomous University of Tamaulipas (MX), The University of Texas Health Science Center at Houston (US)
National Institutes of Health, University of California, San Francisco, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases
Openalex Percentile: Top 16%
Tuberculosis Research and Epidemiology
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.